Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
205,019,647
-
Share change
-
-8,280,145
-
Total reported value
-
$8,343,354,550
-
Put/Call ratio
-
64%
-
Price per share
-
$40.55
-
Number of holders
-
711
-
Value change
-
-$335,054,699
-
Number of buys
-
328
-
Number of sells
-
294
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2016
As of 31 Mar 2016,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
711 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
205,019,647 shares.
The largest 10 holders included
FMR LLC, Fisher Asset Management, LLC, WELLS FARGO & COMPANY/MN, JPMORGAN CHASE & CO, STATE STREET CORP, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, and FEDERATED INVESTORS INC /PA/.
This page lists
711
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.